RT @TalhaBadarMD: Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia https://t.co/kJ…
RT @TalhaBadarMD: Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia https://t.co/kJ…
Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia https://t.co/kJc2oCWmGR RUNX1/CEBPA or RAS-RTK pathway genes is the main driver of acquired resistance; BCOR, homologous IDH gene, and TET2. https://t
So cool Koichi! Looking forward to reading!
RT @DrKTakahashi: Excited to share our recent publication in @NatureComms describing the molecular correlates of IDH inhibitor response in…
"These data suggest that targeting stemness and certain high-risk co-occurring mutations may overcome resistance to IDHi in AML."
RT @NatureComms: #Multiomics analysis by @DrKTakahashi @MDAndersonNews reveals that #resistance to IDH #inhibitors in acute myeloid #leukae…
RT @DrKTakahashi: Excited to share our recent publication in @NatureComms describing the molecular correlates of IDH inhibitor response in…
RT @DrKTakahashi: Excited to share our recent publication in @NatureComms describing the molecular correlates of IDH inhibitor response in…
RT @DrKTakahashi: Excited to share our recent publication in @NatureComms describing the molecular correlates of IDH inhibitor response in…
RT @DrKTakahashi: Excited to share our recent publication in @NatureComms describing the molecular correlates of IDH inhibitor response in…
RT @DrKTakahashi: Excited to share our recent publication in @NatureComms describing the molecular correlates of IDH inhibitor response in…
RT @DrKTakahashi: Excited to share our recent publication in @NatureComms describing the molecular correlates of IDH inhibitor response in…
RT @DrKTakahashi: Excited to share our recent publication in @NatureComms describing the molecular correlates of IDH inhibitor response in…
RT @DrKTakahashi: Excited to share our recent publication in @NatureComms describing the molecular correlates of IDH inhibitor response in…
RT @DrKTakahashi: Excited to share our recent publication in @NatureComms describing the molecular correlates of IDH inhibitor response in…
RT @DrKTakahashi: Excited to share our recent publication in @NatureComms describing the molecular correlates of IDH inhibitor response in…
RT @DrKTakahashi: Excited to share our recent publication in @NatureComms describing the molecular correlates of IDH inhibitor response in…
Excited to share our recent publication in @NatureComms describing the molecular correlates of IDH inhibitor response in AML. We found that stemness signature is predictive of primary resistance to IDH inhibitors while selection of resistant mutations driv
RT @cancerscnews: Scientists in this 🆕 @NatureComms paper reveal that #leukemia stemness is a major driver of primary resistance to isocitr…
Scientists in this 🆕 @NatureComms paper reveal that #leukemia stemness is a major driver of primary resistance to isocitrate dehydrogenase inhibitors. #OpenAccess | https://t.co/z0kJ3m6WnA https://t.co/IZXdIM4CnI
RT @NatureComms: #Multiomics analysis by @DrKTakahashi @MDAndersonNews reveals that #resistance to IDH #inhibitors in acute myeloid #leukae…
'In this work, we perform an integrated genomic analysis combining DNA sequencing, RNA sequencing, and methylation profiling microarray on bone marrow samples collected longitudinally from AML patients treated with IDHi' https://t.co/LkkmGpHrHQ
RT @NatureComms: #Multiomics analysis by @DrKTakahashi @MDAndersonNews reveals that #resistance to IDH #inhibitors in acute myeloid #leukae…
RT @NatureComms: #Multiomics analysis by @DrKTakahashi @MDAndersonNews reveals that #resistance to IDH #inhibitors in acute myeloid #leukae…
RT @NatureComms: #Multiomics analysis by @DrKTakahashi @MDAndersonNews reveals that #resistance to IDH #inhibitors in acute myeloid #leukae…
RT @NatureComms: #Multiomics analysis by @DrKTakahashi @MDAndersonNews reveals that #resistance to IDH #inhibitors in acute myeloid #leukae…
RT @NatureComms: #Multiomics analysis by @DrKTakahashi @MDAndersonNews reveals that #resistance to IDH #inhibitors in acute myeloid #leukae…
RT @NatureComms: #Multiomics analysis by @DrKTakahashi @MDAndersonNews reveals that #resistance to IDH #inhibitors in acute myeloid #leukae…
#Multiomics analysis by @DrKTakahashi @MDAndersonNews reveals that #resistance to IDH #inhibitors in acute myeloid #leukaemia #AML is driven by #stemness and high-risk #mutations 🧬💊 #CancerResearch @NatResCancer https://t.co/VrTKXyNBu2
解析を行なったプロジェクトがNature Communicationsにパブリッシュされました(共著)。 急性骨髄性白血病において、共起する遺伝子変異で白血病幹細胞化が起き、IDH阻害剤への耐性をもたらすことを明らかにしました。 https://t.co/KOR54VpnGg